Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Solvay U.S. CEO (correction)

Executive Summary

Former CEO of the U.S. division of Solvay Pharmaceuticals Harold Shlevin was promoted to the position of global senior VP-regulatory, safety and quality strategies and external affairs for the global Solvay Pharmaceuticals organization. "The Pink Sheet" incorrectly reported his new position (1"The Pink Sheet" Jan. 9, 2006, In Brief)...

You may also be interested in...

Solvay U.S. CEO

The U.S. division of Solvay Pharmaceuticals names Laurence Downey CEO, effective Jan. 1, 2006. Downey, who served as president and CEO of Solvay Pharma Inc. in Canada since 1999, succeeds Harold Shlevin who was promoted to the position of VP-regulatory safety, quality strategies and external affairs within Solvay Pharmaceuticals...

Ready, Set, Guidance: FDA Releases Final Details Ahead Of ASCA Pilot Launch

A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.

With Preservative-Free Alaway Eye Drops, Bausch Expands OTC Portfolio Of Planned Spin-Off

Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals. 




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts